Patents by Inventor Timothy John Bull

Timothy John Bull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acceleration of growth
    Patent number: 10633630
    Abstract: The invention is in the field of growth of Mycobacteria. In particular, agents have been identified which enhance the growth of Mycobacterial species, which are naturally slow-growing. Such agents can therefore be used in the identification of Mycobacteria and in the diagnosis of Mycobacterial infections.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: April 28, 2020
    Assignee: ST GEORGE'S HOSPITAL MEDICAL SCHOOL
    Inventors: Timothy John Bull, Kai Hilpert
  • ACCELERATION OF MYCOBACTERIUM GROWTH
    Publication number: 20170121672
    Abstract: The invention is in the field of growth of Mycobacteria. In particular, agents have been identified which enhance the growth of Mycobacterial species, which are naturally slow-growing. Such agents can therefore be used in the identification of Mycobacteria and in the diagnosis of Mycobacterial infections.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 4, 2017
    Applicant: ST GEORGE'S HOSPITAL MEDICAL SCHOOL
    Inventors: Timothy John Bull, Kai Hilpert
  • Diagnostics and vaccines for mycobacterial infections of animals and humans
    Patent number: 8148136
    Abstract: This invention relates to the protein, Mycobacterium paratuberculosis acylase (mpa) and the gene encoding mpa, which we have identified in the pathogen Mycobacterium paratuberculosis Mptb (also designated Mycobacterium avium subspecies paratuberculosis MAP), and to their use in the diagnosis of Mptb/MAP infections in animals and humans, as well as their use as components of vaccines for the prevention and treatment of diseases caused by Mptb/MAP. The importance of an intact uninterrupted mpa gene as a determinant of pathogenicity in Mptb/MAP is recognized and the invention also provides attenuated strains of normally pathogenic Mptb/MAP and other mycobacteria in which mpa has been inactivated, for use as vaccines.
    Type: Grant
    Filed: March 18, 1999
    Date of Patent: April 3, 2012
    Assignee: HAV Vaccines Limited
    Inventors: John Hermon-Taylor, Timothy John Bull
  • Immunogenic constructs
    Patent number: 8147850
    Abstract: The present invention relates to molecules, which can be used to induce a therapeutic or prophylactic immune response against MAP.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: April 3, 2012
    Assignee: HAV Vaccines Limited
    Inventors: John Hermon-Taylor, Timothy John Bull
  • Immunogenic Constructs
    Publication number: 20110129502
    Abstract: The present invention relates to molecules, which can be used to induce a therapeutic or prophylactic immune response against MAP.
    Type: Application
    Filed: January 14, 2011
    Publication date: June 2, 2011
    Applicant: HAV Vaccines Limited
    Inventors: John Hermon-Taylor, Timothy John Bull
  • Immunogenic constructs
    Patent number: 7892566
    Abstract: The present invention relates to molecules, which can be used to induce a therapeutic or prophylactic immune response against MAP.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: February 22, 2011
    Assignee: HAV Vaccines Limited
    Inventors: John Hermon-Taylor, Timothy John Bull
  • Immunogenic Constructs
    Publication number: 20090203593
    Abstract: The present invention relates to molecules, which can be used to induce a therapeutic or prophylactic immune response against MAP.
    Type: Application
    Filed: August 3, 2006
    Publication date: August 13, 2009
    Applicant: St.Georges Enterprises Limited
    Inventors: John Hermon-Taylor, Timothy John Bull